Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Clinical trial NCT06676527 · RECRUITING
Trial details
- NCT number
- NCT06676527
- Sponsor
- Jinling Hospital, China
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.